Sustained local drug delivery to the arterial wall via biodegradable microspheres.
暂无分享,去创建一个
M. Fishbein | J. Forrester | E. Rechavia | F. Litvack | N. Eigler | A. Hickey | V. Dev | Y. Tian
[1] A. Hickey,et al. Biliary elimination of bromsulphthalein, phenolphthalein, and doxorubicin released from microspheres following intravenous administration , 1993, Biopharmaceutics & drug disposition.
[2] D. Holmes,et al. Restenosis: the clinical problem. , 1993, Coronary artery disease.
[3] D. Faxon,et al. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. , 1993, Coronary artery disease.
[4] M. Leon,et al. New device angioplasty: the impact on restenosis. , 1993, Coronary artery disease.
[5] E J Topol,et al. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.
[6] J. Isner,et al. Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. , 1992, The Journal of clinical investigation.
[7] K. Robinson,et al. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. , 1992, Journal of the American College of Cardiology.
[8] J. O’Keefe,et al. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. , 1992, Journal of the American College of Cardiology.
[9] P. Flandroy,et al. Preparation of poly (D,L) lactide microspheres by emulsion-solvent evaporation, and their clinical applications as a convenient embolic material. , 1992, Journal of biomedical materials research.
[10] R. Califf,et al. Clinical trials of restenosis after coronary angioplasty. , 1991, Circulation.
[11] I. Lancranjan,et al. Parenteral depot-systems on the basis of biodegradable polyesters , 1991 .
[12] E. Topol,et al. Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. , 1991, Journal of the American College of Cardiology.
[13] M. Fishbein,et al. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. , 1991, Journal of the American College of Cardiology.
[14] M. Savage,et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group. , 1990, Circulation.
[15] S. Thung,et al. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. , 1990, Journal of the American College of Cardiology.
[16] G. Stone,et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. , 1989, Catheterization and cardiovascular diagnosis.
[17] J. Feijen,et al. In vivo and in vitro degradation of glycine/DL-lactic acid copolymers. , 1989, Journal of biomedical materials research.
[18] C. Pepine,et al. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. , 1987, The American journal of cardiology.
[19] G E Visscher,et al. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.
[20] E. Braunwald,et al. Mummification of the Infarcted Myocardium by High Dose Corticosteroids , 1978, Circulation.
[21] A. Hickey,et al. Manufacture and In-Vitro Assessment of Bromsulphthalein and Phenolphthalein Loaded Polyester Microspheres , 1994 .
[22] T. Tice,et al. Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. , 1985, Methods in enzymology.
[23] W. J. Larson,et al. Degradation rates of polymers and copolymers of polylactic and polyglycolic acids. , 1974, Oral surgery, oral medicine, and oral pathology.
[24] W. Cohn. [13] The isolation and characterization of pseudouridine☆ , 1967 .